Focal lesions of the liver in the course of retroperitoneal fibrosis – case report and brief review of the literature

Authors

  • Lilianna Kołodziej-Spirodek Kliniczny Oddział Gastroenterologii i Hepatologii z Pododdziałem Chorób Wewnętrznych Wojewódzkiego Szpitala Specjalistycznego w Rzeszowie
  • Agnieszka Rusiecka Kliniczny Oddział Gastroenterologii i Hepatologii z Pododdziałem Chorób Wewnętrznych Wojewódzkiego Szpitala Specjalistycznego w Rzeszowie
  • Karolina Hunia-Pająk Kliniczny Oddział Gastroenterologii i Hepatologii z Pododdziałem Chorób Wewnętrznych Wojewódzkiego Szpitala Specjalistycznego w Rzeszowie
  • Krzysztof Gutkowski Kliniczny Oddział Gastroenterologii i Hepatologii z Pododdziałem Chorób Wewnętrznych Wojewódzkiego Szpitala Specjalistycznego w Rzeszowie; Instytut Fizjoterapii Wydziału Medycznego Uniwersytetu Rzeszowskiego

DOI:

https://doi.org/10.15584/przmed.2015.2.11

Keywords:

retroperitoneal fibrosis, focal lesions of the liver, glicocorticotherapy

Abstract

Retroperitoneal fibrosis, (RF) is a rare disease characterized by proliferation of pathological fibrous tissue in the retroperitoneum. Changes are mostly located around abdominal aorta, inferior vena cava and ureters. The fibrosis can also appear in untypical locations and reach other organs of abdominal cavity. Etiology of the disease is unknown, although it is supposed to be related to autoimmune processes. The major role in RF diagnostics play radiology and histopathology. The treatment is based on corticosteroids, immunosuppressive drugs and surgery. Prognosis depends on early diagnosis and implementation of a proper therapy. We present a case of 53 years old female patient with focal lesions within the liver in the course of the RF which have undergone significant regression in the course of glycocorticotherapy and brief review of the literature.

Downloads

Download data is not yet available.

References

Day K, Nikolaidis P, Casalino DD. Retroperitoneal fibrosis. J Urol 2012; 4: 1440-1441. doi: 10.1016/j.juro.2012.01.025

Zielonko J, Obołończyk L. Retroperitoneal fibrosis with pancreatic involvement – radiological appearance. Pol J Radiol 2011; 4: 69-72.

Wołyniec W, Kożuchowska M, Różańska-Kluziak A, et al. Zwłóknienie pozaotrzewnowe – opis 15 przypadków oraz przegląd piśmiennictwa polskiego. Nefrologia i Dializoterapia Polska 2007; 11: 133-140.

Swartz R, Scheel P. Retroperitoneal fibrosis: gaining traction on an enigma. Lancet 2011; 9788: 294-296. doi: 10.1016/S0140-6736(11)60880-5

Yilmaz S, Tan YZ, Ozhan M, et al. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis. Rev Esp Med Nucl Imagen Mol 2012; 6: 338-339. doi: 10.1016/j.remnie.2012.10.004

Scheel PJ, Feeley N. Retroperitoneal Fibrosis. Rheum Dis Clin North Am 2013;2: 365-381. doi: 10.1016/j.rdc.2013.02.004

Vaglio A, Palmisano A, Corradi D, et al. Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin North Am 2007; 4: 803-817. doi: 10.1016/j.rdc.2007.07.013

Babski P, Wojtuń S, GIL J. Włóknienie zaotrzewnowe. Pol Merkur Lekarski 2007; 131: 499.

Pipitone N, Vaglio A, Salvarani C. Retroperitoneal Fibrosis. Best Pract Res Clin Rheumatol 2012;4: 439-48. doi: 10.1016/j.berh.2012.07.004

Van Bommel EF, Pelkmans LG, van Damme H, et al. Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med 2013;5: 444-450. doi: 10.1016/j.ejim.2012.11.010

Vaglio A, Palmisano A. Treatment of retroperitoneal fibrosis. UptoDate 2014. URL: http://www.uptodate.com/contents/treatment-of-retroperitoneal-fibrosis

Catanoso MG, Spaggiari L, Magnani L, et al. Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol 2012;5: 776-778.

Alberti N, Frulio N, Bertolotti A, et al. Erdheim-Chester disease: A rare diagnosis with evocative imaging. Diagn Interv Imaging 2013; 4: 457-459. doi: 10.1016/j.diii.2013.01.007

Downloads

Published

2015-06-30

How to Cite

Kołodziej-Spirodek, L., Rusiecka, A., Hunia-Pająk, K., & Gutkowski, K. (2015). Focal lesions of the liver in the course of retroperitoneal fibrosis – case report and brief review of the literature. European Journal of Clinical and Experimental Medicine, 13(2), 180–186. https://doi.org/10.15584/przmed.2015.2.11

Issue

Vol. 13 No. 2 (2015): Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw

Section

CASUISTIC PAPERS

License

Copyright (c) 2015 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.

Most read articles by the same author(s)